Synthetic progesterone derivatives, particularly medrogestone, medroxyprogesterone acetate and promegestone, have been linked to a significantly increased risk of intracranial meningiomas, especially with long-term use exceeding one year.
Category: FEATURED GUEST ARTICLE by Dr. Joseph Mercola – Oct 8 2024